Skip to content
Facebook Instagram Linkedin

LifeScienceHistory.com

History made daily

  • Home
  • DirectoryExpand
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • News and History
  • Cartoons
  • Small World
  • Earth is a RockExpand
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
LifeScienceHistory.com
History made daily
Home / Blog - Page 76

Blog

USDA confirmed highly pathogenic Avian influenza in Minnesota
Agriculture | Biotechnology | Diagnostics | Infectious Disease | Influenza | USDA | Veterinary

USDA confirmed highly pathogenic Avian influenza in Minnesota

On Mar. 25, 2022, the U.S. Department of Agriculture’s (USDA) Animal and Plant Health Inspection Service (APHIS) confirmed…

Read More USDA confirmed highly pathogenic Avian influenza in MinnesotaContinue

US Food and Drug Administration revised EUA for sotrovimab due to Omicron BA.2 subvariant
Biotechnology | FDA | Life Science History

US Food and Drug Administration revised EUA for sotrovimab due to Omicron BA.2 subvariant

On Mar. 25, 2022, GlaxoSmithKline and Vir Biotechnology announced that the US Food and Drug Administration had amended…

Read More US Food and Drug Administration revised EUA for sotrovimab due to Omicron BA.2 subvariantContinue

Moderna finalized strategic partnership with Australian government
Biotechnology | COVID-19 | Infectious Disease | Vaccine

Moderna finalized strategic partnership with Australian government

On Mar. 23, 2022, Moderna announced the finalization of a strategic partnership with the Australian Federal Government to…

Read More Moderna finalized strategic partnership with Australian governmentContinue

Moderna announced COVID-19 vaccine phase 2/3 study in children 6 months to Under 6 years met Its primary endpoint
Biotechnology | COVID-19 | Infectious Disease | Vaccine

Moderna announced COVID-19 vaccine phase 2/3 study in children 6 months to Under 6 years met Its primary endpoint

On Mar. 23, 2022, Moderna announced positive interim data from the Phase 2/3 KidCOVE study of the Moderna…

Read More Moderna announced COVID-19 vaccine phase 2/3 study in children 6 months to Under 6 years met Its primary endpointContinue

Quest Diagnostics granted CDC contract to support COVID-19 infection and vaccination seroprevalence research
CDC | COVID-19 | Life Science History

Quest Diagnostics granted CDC contract to support COVID-19 infection and vaccination seroprevalence research

On Mar. 23, 2022, Quest Diagnostics announced that it had been granted a contract by the Centers for…

Read More Quest Diagnostics granted CDC contract to support COVID-19 infection and vaccination seroprevalence researchContinue

Windtree announced results from phase 2 study of lucinactant for COVID-19 associated ARDS and Lung Injury
COVID-19 | Life Science History

Windtree announced results from phase 2 study of lucinactant for COVID-19 associated ARDS and Lung Injury

On Mar. 22, 2022, Windtree Therapeutics announced results from its Phase 2 study of lucinactant (KL4 surfactant) for…

Read More Windtree announced results from phase 2 study of lucinactant for COVID-19 associated ARDS and Lung InjuryContinue

Pfizer supplied UNICEF 4 million treatment courses of novel COVID-19 oral treatment for low- and middle-Income countries
Biotechnology | COVID-19 | Infectious Disease | Therapeutics

Pfizer supplied UNICEF 4 million treatment courses of novel COVID-19 oral treatment for low- and middle-Income countries

On Mar. 22, 2022, Pfizer announced an agreement with UNICEF to supply up to 4 million treatment courses…

Read More Pfizer supplied UNICEF 4 million treatment courses of novel COVID-19 oral treatment for low- and middle-Income countriesContinue

Moderna announced new supply agreement for 2023 with Switzerland for seven million doses of COVID-19 booster vaccine
Biotechnology | COVID-19 | Infectious Disease | Vaccine

Moderna announced new supply agreement for 2023 with Switzerland for seven million doses of COVID-19 booster vaccine

On Mar. 21, 2022, Moderna announced announced a supply agreement with the Swiss Federal Government for seven million…

Read More Moderna announced new supply agreement for 2023 with Switzerland for seven million doses of COVID-19 booster vaccineContinue

Twist Bioscience launched synthetic RNA positive controls for SARS-CoV-2 encapsulated in imagene’s stainless steel capsules
Biotechnology | COVID-19 | Infectious Disease | Therapeutics

Twist Bioscience launched synthetic RNA positive controls for SARS-CoV-2 encapsulated in imagene’s stainless steel capsules

On Mar. 21, 2022, Twist Bioscience announced the launch of specific synthetic RNA positive controls for SARS-CoV-2 encapsulated…

Read More Twist Bioscience launched synthetic RNA positive controls for SARS-CoV-2 encapsulated in imagene’s stainless steel capsulesContinue

NIH launched program to offer molecular characterization of childhood cancers
Life Science History

NIH launched program to offer molecular characterization of childhood cancers

On Mar. 21, 2022, in support of the Cancer Moonshot? goal of fostering data sharing in cancer research,…

Read More NIH launched program to offer molecular characterization of childhood cancersContinue

Researchers generated the first complete, gapless sequence of a human genome
Biotechnology | Diagnostics | Genomics | Medicine | Therapeutics

Researchers generated the first complete, gapless sequence of a human genome

On Mar. 21, 2022, in support of the Cancer Moonshot goal of fostering data sharing in cancer research,…

Read More Researchers generated the first complete, gapless sequence of a human genomeContinue

The Priestley Medal was awarded to Peter B. Dervan
Biotechnology | Chemistry

The Priestley Medal was awarded to Peter B. Dervan

On Mar. 20, 2022, the American Chemical Society awarded The Priestley Medal to Peter B. Dervan “to recognize…

Read More The Priestley Medal was awarded to Peter B. DervanContinue

More than 80 million doses administered to southern African children targeted in mass polio vaccination drives
Biotechnology | Infectious Disease | Polio | Vaccine | WHO

More than 80 million doses administered to southern African children targeted in mass polio vaccination drives

On Mar. 18, 2022, the World Health Organization (WHO) announced that Malawi had launched the first round of…

Read More More than 80 million doses administered to southern African children targeted in mass polio vaccination drivesContinue

Johnson & Johnson announced acquisition of Tibotec-Virco NV for $320 million in cash and debt
Biotechnology | HIV | Infectious Disease | Therapeutics

Johnson & Johnson announced acquisition of Tibotec-Virco NV for $320 million in cash and debt

On Mar. 18, 2002, Johnson & Johnson announced an agreement to acquire all of the assets of Tibotec-Virco…

Read More Johnson & Johnson announced acquisition of Tibotec-Virco NV for $320 million in cash and debtContinue

Health Canada authorized Moderna’s COVID-19 vaccine in children (6-11 Years)
Biotechnology | COVID-19 | Infectious Disease | Vaccine

Health Canada authorized Moderna’s COVID-19 vaccine in children (6-11 Years)

On Mar. 17, 2022, Moderna announced that Health Canada had approved the use of Moderna’s mRNA COVID-19 vaccine,…

Read More Health Canada authorized Moderna’s COVID-19 vaccine in children (6-11 Years)Continue

Soligenix COVID-19 vaccine, CiVax, boosted neutralizing activity against SARS-CoV-2, including Delta and Omicron
Biotechnology | COVID-19 | Therapeutics | Vaccine

Soligenix COVID-19 vaccine, CiVax, boosted neutralizing activity against SARS-CoV-2, including Delta and Omicron

On Mar. 17, 2022, Soligenix announced the results of a booster vaccination study using CiVax (heat stable COVID-19…

Read More Soligenix COVID-19 vaccine, CiVax, boosted neutralizing activity against SARS-CoV-2, including Delta and OmicronContinue

Eiger’s single-dose Peginterferon Lambda for COVID-19 reduced risk of hospitalization or ER visits by 50% in vaccinated population
COVID-19 | Life Science History | Vaccine

Eiger’s single-dose Peginterferon Lambda for COVID-19 reduced risk of hospitalization or ER visits by 50% in vaccinated population

On Mar. 17, 2022, Eiger BioPharmaceuticals announced that Peginterferon Lambda (Lambda) significantly reduced the risk of COVID-19-related hospitalizations…

Read More Eiger’s single-dose Peginterferon Lambda for COVID-19 reduced risk of hospitalization or ER visits by 50% in vaccinated populationContinue

USDA confirmed highly pathogenic Avian influenza in non-commercial backyard flock (Non-Poultry) in New Hampshire
Agriculture | Biotechnology | Diagnostics | Infectious Disease | Influenza

USDA confirmed highly pathogenic Avian influenza in non-commercial backyard flock (Non-Poultry) in New Hampshire

On Mar. 17, 2022, the U.S. Department of Agriculture’s (USDA) Animal and Plant Health Inspection Service confirmed (APHIS)…

Read More USDA confirmed highly pathogenic Avian influenza in non-commercial backyard flock (Non-Poultry) in New HampshireContinue

NIHメs All of Us Research program released first genomic dataset of nearly 100,000 whole genome sequences
Genomics | NIH | Therapeutics

NIHメs All of Us Research program released first genomic dataset of nearly 100,000 whole genome sequences

On Mar. 17, 2022, the National Institutes of Health announced that nearly 100,000 highly diverse whole genome sequences…

Read More NIHメs All of Us Research program released first genomic dataset of nearly 100,000 whole genome sequencesContinue

Moderna submited amendment to EUA for an additional booster dose of its COVID-19 vaccine in the U.S.
Biotechnology | COVID-19 | FDA | Infectious Disease | Vaccine

Moderna submited amendment to EUA for an additional booster dose of its COVID-19 vaccine in the U.S.

On Mar. 17, 2022, Moderna announced that it had submitted a request to the U.S. Food and Drug…

Read More Moderna submited amendment to EUA for an additional booster dose of its COVID-19 vaccine in the U.S.Continue

Moderna to supply Japan with additional 70 million doses of COVID-19 booster vaccine
Biotechnology | COVID-19 | Infectious Disease | Vaccine

Moderna to supply Japan with additional 70 million doses of COVID-19 booster vaccine

On Mar. 16, 2022, Moderna announced an agreement with the Ministry of Health, Labour and Welfare of Japan…

Read More Moderna to supply Japan with additional 70 million doses of COVID-19 booster vaccineContinue

USDA confirmed highly pathogenic Avian influenza non-commercial backyard fock in Nebraska
Agriculture | Biotechnology | Diagnostics | Infectious Disease | Influenza | USDA | Veterinary

USDA confirmed highly pathogenic Avian influenza non-commercial backyard fock in Nebraska

On Mar. 16, 2022, the U.S. Department of Agriculture’s (USDA) Animal and Plant Health Inspection Service (APHIS) confirmed…

Read More USDA confirmed highly pathogenic Avian influenza non-commercial backyard fock in NebraskaContinue

Roche provided molecular testing solutions to identify and differentiate SARS-CoV-2 Omicron variants of concern
Life Science History

Roche provided molecular testing solutions to identify and differentiate SARS-CoV-2 Omicron variants of concern

On Mar. 16, 2022, Roche announced available testing solutions that can identify the SARS-CoV-2 B.1.1.529 variant and differentiate…

Read More Roche provided molecular testing solutions to identify and differentiate SARS-CoV-2 Omicron variants of concernContinue

Pfizer and BioNTech submitted for U.S. EUA of additional booster dose of COVID-19 vaccine for older adults
Biotechnology | COVID-19 | Vaccine

Pfizer and BioNTech submitted for U.S. EUA of additional booster dose of COVID-19 vaccine for older adults

On Mar. 15, 2022, Pfizer and BioNTech announced the companies had submitted an application to the U.S. Food…

Read More Pfizer and BioNTech submitted for U.S. EUA of additional booster dose of COVID-19 vaccine for older adultsContinue

NIH launched clinical trial of three mRNA HIV vaccines
COVID-19 | HIV | NIH | Non-Profit Research | Vaccine

NIH launched clinical trial of three mRNA HIV vaccines

On Mar. 14, 2022, researchers from the National Institute of Allergy and Infectious Diseases (NIAID) announced they had…

Read More NIH launched clinical trial of three mRNA HIV vaccinesContinue

USDA confirmed highly pathogenic Avian influenza in Wisconsin
Agriculture | Biotechnology | Diagnostics | Infectious Disease | Influenza | USDA | Veterinary

USDA confirmed highly pathogenic Avian influenza in Wisconsin

On Mar. 14, 2022, the U.S. Department of Agriculture’s (USDA) Animal and Plant Health Inspection (APHIS) Service confirmed…

Read More USDA confirmed highly pathogenic Avian influenza in WisconsinContinue

CDC reported effectiveness of 2-Dose BNT162b2 mRNA vaccine in preventing SARS-CoV-2 infection among children
CDC | COVID-19 | Life Science History

CDC reported effectiveness of 2-Dose BNT162b2 mRNA vaccine in preventing SARS-CoV-2 infection among children

On Mar. 11, 2022, the BNT162b2 (Pfizer-BioNTech) mRNA COVID-19 vaccine was recommended by CDCメs Advisory Committee on Immunization…

Read More CDC reported effectiveness of 2-Dose BNT162b2 mRNA vaccine in preventing SARS-CoV-2 infection among childrenContinue

Cocrystal Pharma initiated enrollment in phase 1 influenza a study with novel, broad-spectrum, orally administrated antiviral CC-42344
Biotechnology | Disease | Infectious Disease | Influenza | Therapeutics

Cocrystal Pharma initiated enrollment in phase 1 influenza a study with novel, broad-spectrum, orally administrated antiviral CC-42344

On Mar. 10, 2022, Cocrystal Pharma announced dosing of the first subjects in a Phase 1 clinical trial…

Read More Cocrystal Pharma initiated enrollment in phase 1 influenza a study with novel, broad-spectrum, orally administrated antiviral CC-42344Continue

Mandatory masking in schools reduced COVID-19 cases during Delta surge
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | NIH | Therapeutics

Mandatory masking in schools reduced COVID-19 cases during Delta surge

On Mar. 10, 2022, schools with mandatory masking during the Delta surge had approximately 72% fewer cases of…

Read More Mandatory masking in schools reduced COVID-19 cases during Delta surgeContinue

IHME reported three times as many deaths worldwide due to COVID-19 than official reports suggested
COVID-19 | Therapeutics | Vaccine

IHME reported three times as many deaths worldwide due to COVID-19 than official reports suggested

On Mar. 10, 2022, the Institute for Health Metrics and Evaluation (IHME) reported that more than three times…

Read More IHME reported three times as many deaths worldwide due to COVID-19 than official reports suggestedContinue

Page navigation

Previous PagePrevious 1 … 74 75 76 77 78 … 362 Next PageNext
  • Categories
  • Timeline
  • Aesthetics
  • Agriculture
  • Artificial Intelligence
  • Biology
  • Biotechnology
  • Cardiology
  • Cartoons – Historical
  • Cartoons – Original
  • CDC
  • CDMO
  • Chemistry
  • Clinical Research
  • Cloning
  • CMO
  • COVID-19
  • CRISPR
  • CRO
  • Cryogenic
  • Dentistry
  • Diagnostics
  • Disease
  • Energy
  • Environmental
  • EPA
  • FDA
  • Forestry
  • Genomics
  • HIV
  • Infectious Disease
  • Influenza
  • IRB
  • Life Science History
  • Marine Science
  • Materials
  • Measles
  • Medical Device
  • Medicine
  • Nanotechnology
  • Neurology
  • NIH
  • Non-Profit Research
  • Nutraceuticals
  • Oncology
  • Ophthalmogy
  • Organ Transplant
  • Orthopedic
  • Other
  • Pharmaceutical
  • Plague
  • Polio
  • Prehistory
  • Quantum
  • Radiology
  • Rare Disease
  • Stem Cell
  • Therapeutics
  • U.S. Congress
  • Uncategorized
  • USDA
  • Vaccine
  • Veterinary
  • WHO
  • Women's Health
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005
  • 2004
  • 2003
  • 2002
  • 2001
  • 2000
  • 1999
  • 1998
  • 1997
  • 1996
  • 1995
  • 1994
  • 1993
  • 1992
  • 1991
  • 1990
  • 1989
  • 1988
  • 1987
  • 1986
  • 1985
  • 1984
  • 1983
  • 1982
  • 1981
  • 1980
  • 1979
  • 1978
  • 1977
  • 1976
  • 1975
  • 1974
  • 1973
  • 1972
  • 1971
  • 1970
  • 1969
  • 1968
  • 1967
  • 1966
  • 1965
  • 1964
  • 1963
  • 1962
  • 1961
  • 1960
  • 1959
  • 1958
  • 1957
  • 1956
  • 1955
  • 1954
  • 1953
  • 1952
  • 1951
  • 1950
  • 1949
  • 1948
  • 1947
  • 1946
  • 1945
  • 1944
  • 1943
  • 1942
  • 1941
  • 1940
  • 1939
  • 1938
  • 1937
  • 1936
  • 1935
  • 1934
  • 1933
  • 1932
  • 1931
  • 1930
  • 1929
  • 1928
  • 1927
  • 1926
  • 1925
  • 1924
  • 1923
  • 1922
  • 1921
  • 1920
  • 1919
  • 1918
  • 1917
  • 1916
  • 1915
  • 1914
  • 1913
  • 1912
  • 1911
  • 1910
  • 1909
  • 1908
  • 1907
  • 1906
  • 1905
  • 1904
  • 1903
  • 1902
  • 1901
  • 1900
  • 1899
  • 1898
  • 1897
  • 1896
  • 1895
  • 1894
  • 1893
  • 1892
  • 1891
  • 1890
  • 1889
  • 1888
  • 1887
  • 1886
  • 1885
  • 1884
  • 1883
  • 1882
  • 1881
  • 1880
  • 1879
  • 1878
  • 1877
  • 1876
  • 1875
  • 1874
  • 1873
  • 1872
  • 1871
  • 1870
  • 1869
  • 1868
  • 1867
  • 1866
  • 1865
  • 1864
  • 1863
  • 1862
  • 1861
  • 1860
  • 1859
  • 1858
  • 1857
  • 1856
  • 1855
  • 1854
  • 1853
  • 1852
  • 1851
  • 1850
  • 1849
  • 1848
  • 1847
  • 1846
  • 1845
  • 1844
  • 1843
  • 1842
  • 1840
  • 1839
  • 1838
  • 1837
  • 1836
  • 1834
  • 1833
  • 1832
  • 1831
  • 1830
  • 1828
  • 1827
  • 1826
  • 1825
  • 1824
  • 1823
  • 1820
  • 1819
  • 1818
  • 1817
  • 1816
  • 1813
  • 1811
  • 1810
  • 1809
  • 1808
  • 1804
  • 1802
  • 1801
  • 1800
  • 1799
  • 1798
  • 1796
  • 1795
  • 1794
  • 1793
  • 1790
  • 1789
  • 1788
  • 1786
  • 1785
  • 1784
  • 1782
  • 1781
  • 1777
  • 1769
  • 1765
  • 1761
  • 1753
  • 1751
  • 1749
  • 1747
  • 1746
  • 1743
  • 1741
  • 1738
  • 1727
  • 1723
  • 1721
  • 1720
  • 1718
  • 1716
  • 1712
  • 1697
  • 1693
  • 1683
  • 1674
  • 1667
  • 1666
  • 1665
  • 1664
  • 1663
  • 1658
  • 1656
  • 1647
  • 1636
  • 1634
  • 1629
  • 1621
  • 1603
  • 1580
  • 1521
  • 1510
  • 1403
  • 1377
  • 1370
  • 1363
  • 1348
  • 1346
  • 1322
  • 1285
  • 1202
  • 1200
  • 1179
  • 1100
  • 1050
  • 541
  • 470
  • 1
Subscribe to E-History

Subscribe

* indicates required

LifeScienceHistory.com

LifeScienceHistory.com Where history is made daily, is a comprehensive companion of life science. Simply put, we dig history and we mine data.

More

  • About
  • Life Science Heroes

Advertising

  • Banner Advertising

Legal

  • Privacy Policy
  • Terms of Use

© 2025 LifeScienceHistory.com by James Web Design

Facebook Instagram Linkedin
  • Home
  • Directory
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • News and History
  • Cartoons
  • Small World
  • Earth is a Rock
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
Search